⭐️⭐️⭐️⭐️⭐️ "A total no brainer"

⭐️⭐️⭐️⭐️⭐️ "Love this, so easy."

Spots is the easy way to track your skin, mole and cancer changes.

Spots Global Cancer Trial Database for Study of Irofulven in Patients With Hormone-refractory Prostate Cancer

The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.

Trial Identification

Brief Title: Study of Irofulven in Patients With Hormone-refractory Prostate Cancer

Official Title: Three-Arm Randomized Phase II Clinical Study of Irofulven/Prednisone, Irofulven/Capecitabine/Prednisone or Mitoxantrone/Prednisone in Docetaxel-Pretreated Hormone-Refractory Prostate Cancer Patients

Study ID: NCT00124566

Conditions

Prostate Cancer

Study Description

Brief Summary: The purpose of this study is to assess the efficacy and safety of irofulven-based regimens compared to mitoxantrone plus prednisone in patients with hormone-refractory prostate cancer (HRPC) whose disease has progressed following Taxotere based regimens.

Detailed Description: For every five patients randomized, two will receive treatment number 1 (irofulven + prednisone), two patients will receive treatment number 2 (irofulven + capecitabine (Xeloda®) + prednisone), and one patient will receive treatment number 3 (mitoxantrone + prednisone). This is not a blinded study, so both the patient and doctor will know which treatment has been assigned.

Eligibility

Minimum Age: 18 Years

Eligible Ages: ADULT, OLDER_ADULT

Sex: MALE

Healthy Volunteers: No

Locations

, Hot Springs, Arkansas, United States

, Jonesboro, Arkansas, United States

, Greenbrae, California, United States

, Colorado Springs, Colorado, United States

, Bonita Springs, Florida, United States

, Bradenton, Florida, United States

, Cape Coral, Florida, United States

, Ft. Meyers, Florida, United States

, Naples, Florida, United States

, Port Charlotte, Florida, United States

, Sarasota, Florida, United States

, Venice, Florida, United States

, Atlanta, Georgia, United States

, Augusta, Georgia, United States

, Macon, Georgia, United States

, Marietta, Georgia, United States

, Chicago, Illinois, United States

, Minneapolis, Minnesota, United States

, Billings, Montana, United States

, Albany, New York, United States

, East Setauket, New York, United States

, Kettering, Ohio, United States

, Greenville, South Carolina, United States

, Nashville, Tennessee, United States

, Dallas, Texas, United States

, Ft. Worth, Texas, United States

, Tyler, Texas, United States

, Spokane, Washington, United States

, Marshfield, Wisconsin, United States

, Belo Horizonte, , Brazil

, Porto Alegre, , Brazil

, Rio de Janeiro, , Brazil

, Calgary, Alberta, Canada

, Vancouver, British Columbia, Canada

, Winnipeg, Manitoba, Canada

, London, Ontario, Canada

, Montreal, Quebec, Canada

, Santiago, , Chile

, Zagreb, , Croatia

, Avignon, , France

, Orleans, , France

, Paris, , France

, Saint-Brieuc, , France

, Saint-Gregoire, , France

, Lima, , Peru

, Bucharest, , Romania

, Cluj-Napoca, , Romania

, Arkhangelsk, , Russian Federation

, Chelyabinsk, , Russian Federation

, Moscow, , Russian Federation

Contact Details

Useful links and downloads for this trial

Clinicaltrials.gov

Google Search Results

Logo

Take Control of Your Skin and Body Changes Today.

Try out Spots for free, set up only takes 2 mins.

spots app storespots app store

Join others from around the world: